COVID-19 epidemic investigation study of a follow-up cohort of patients with diabetic kidney disease.
Qian Wang, Zheyi Dong, Weiguang Zhang...
https://pubmed.ncbi.nlm.nih.gov/39228893/Actively Recruiting
Led by Chinese PLA General Hospital · Updated on 2023-06-05
2000
Participants Needed
1
Research Sites
8 weeks
Total Duration
Diabetic nephropathy is a serious complication affecting the kidneys in people with type 2 diabetes and is a leading cause of disability and death among these patients. This research is focused on better understanding the development and progression of type 2 diabetic nephropathy by using sensitive biomarkers, imaging of small blood vessels, functional tests, and digital markers. The goal is to establish a long-term follow-up group and create a comprehensive, multidimensional diagnostic and staging system that integrates traditional Chinese and western medicine approaches. The study will categorize participants into groups based on their kidney pathology results as well as clinical features like kidney function and protein levels in urine. This observational study does not involve specific drug treatments but rather aims to develop and evaluate non-invasive diagnostic models and digital markers to improve accurate diagnosis and treatment strategies for type 2 diabetic nephropathy. Participants will be followed over time with regular assessments that include measuring changes in kidney function, specifically the estimated glomerular filtration rate eGFR over 24 months. Researchers will collect detailed medical histories, clinical data, and various test results to track disease progression. This long-term observation will help identify new diagnostic markers and improve clinical staging for better patient care.
CONDITIONS
Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy
Z
Zheyi Dong, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Chinese PLA General Hospital
Lead Sponsor
Beijing Municipal Science & Technology Commission
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - At baseline
Participants undergo assessments including renal biopsy and clinical evaluations to classify type 2 diabetic nephropathy based on pathological and clinical features.
1 visit (in-person)
Duration - 24 months
Participants are monitored over time to observe changes in kidney function and disease progression.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Qian Wang, Zheyi Dong, Weiguang Zhang...
https://pubmed.ncbi.nlm.nih.gov/39228893/Chinese PLA General Hospital
Lead Sponsor
Beijing Municipal Science & Technology Commission
Collaborating Sponsor